静脉补液治疗妊娠晚期临界性羊水过少临床价值(1)
[摘要] 目的 主要探究分析静脉补液治疗妊娠晚期临界性羊水过少的临床应用价值。 方法 随机选取该院妇产科2016年11月—2017年11月的妊娠晚期临界性羊水过少的孕妇210例，按照两组不同的治疗措施，随机把210例孕妇分为对照组和实验组，实验组孕妇110例，对照组孕妇100例。实验组孕妇采取静脉输液治疗的方法，对照组孕妇不给予任何输液治疗，只对孕妇的日常生活行为进行观察。比较两组孕妇的羊水深度、羊水指数、胎儿发生宫内窘迫和新生儿发生窒息的情况。结果 实验组孕妇的羊水深度治疗前是(2.71±1.51)cm，治疗后是(3.59±1.51)cm，羊水指数治疗前是(5.92±1.51)cm，治疗后是(7.82±1.53)cm；胎儿发生宫内窘迫3例，发生率为2.72%，新生儿发生窒息6例，发生率为5.45%；对照组孕妇的羊水深度治疗前是(2.81±0.29)cm，治疗后是(3.54±1.47)cm，羊水指数治疗前是(6.12±1.49)cm，治疗后是(7.91±1.62)cm，胎儿发生宫内窘迫3例，发生率为3.00%，新生儿发生窒息7例，发生率为7.00%。实验组孕妇的羊水深度和羊水指数与对照组孕妇的差异不大，根据统计学分析，差异无统计学意义(P>0.05)。实验组孕妇胎儿发生宫内窘迫和新生儿发生窒息的概率与对照组孕妇相近，根据统计学分析，差异无统计学意义(P>0.05)。结論 对妊娠晚期临界性羊水过少的孕妇进行治疗时，在保证胎儿心率正常的情况下，给予孕妇静脉输液治疗没有明显的疗效，无显著的临床意义，治疗时，应该让孕妇进行具体检查，明确病因，从而对症治疗。
[关键词] 妊娠晚期；临界性羊水过少；静脉补液；临床价值
[中图分类号] R714 [文献标识码] A [文章编号] 1674-0742(2018)06(c)-0067-03
[Abstract] Objective This paper tries to investigate and analyze the clinical value of intravenous fluid in the treatment of critical oligohydramnios in late pregnancy. Methods 210 pregnant women with critical oligohydramnios in late pregnancy from November 2016 to November 2017 in the Department of Obstetrics and Gynecology of the hospital were randomly selected according to two groups of different treatment measures， 210 pregnant women were randomly divided into control group and experimental group. There were 110 pregnant women in the experimental group and 100 pregnant women in the control group. The pregnant women in the experimental group took intravenous infusion therapy. In the control group， pregnant women did not receive any infusion therapy. Only the daily activities of pregnant women were observed. The amniotic fluid depth， amniotic fluid index， intrauterine distress and neonatal asphyxia of the two groups of pregnant women were compared. Results The depth of amniotic fluid in the experimental group was (2.71±1.51)cm before treatment， (3.59±1.51)cm after treatment， (5.92±1.51)cm before amniotic fluid index treatment， (7.82±1.53)cm after treatment， and 3 cases of fetal distress within the fetus. The incidence rate was 2.72%. There were 6 cases of asphyxia in newborns and the incidence was 5.45%. In the control group， the amniotic fluid depth was (2.81±0.29)cm before treatment， (3.54±1.47)cm after treatment，(6.12±1.49)cm before amniotic fluid index treatment， and (7.91±1.62)cm after treatment. There were 3 cases of intrauterine distress， the incidence was 3.00%， 7 cases of neonatal asphyxia， and the incidence was 7.00%. The amniotic fluid depth and amniotic fluid index of pregnant women in the experimental group were not significantly different from those in the control group. According to statistical analysis， the difference was not statistically significant (P>0.05). The probability of occurrence of intrauterine distress and neonatal asphyxia in fetuses of the experimental group was similar to that of pregnant women in the control group. According to statistical analysis， the difference was not statistically significant (P>0.05). Conclusion For the treatment of pregnant women with critical oligohydramnios in late pregnancy， to ensure that the normal fetal heart rate， to give pregnant women intravenous infusion therapy has no obvious curative effect， no significant clinical significance， during the treatment， pregnant women should be specifically checked， clear of etiology， thus symptomatic treatment., http://www.100md.com(杨妍)
[关键词] 妊娠晚期；临界性羊水过少；静脉补液；临床价值
[中图分类号] R714 [文献标识码] A [文章编号] 1674-0742(2018)06(c)-0067-03
[Abstract] Objective This paper tries to investigate and analyze the clinical value of intravenous fluid in the treatment of critical oligohydramnios in late pregnancy. Methods 210 pregnant women with critical oligohydramnios in late pregnancy from November 2016 to November 2017 in the Department of Obstetrics and Gynecology of the hospital were randomly selected according to two groups of different treatment measures， 210 pregnant women were randomly divided into control group and experimental group. There were 110 pregnant women in the experimental group and 100 pregnant women in the control group. The pregnant women in the experimental group took intravenous infusion therapy. In the control group， pregnant women did not receive any infusion therapy. Only the daily activities of pregnant women were observed. The amniotic fluid depth， amniotic fluid index， intrauterine distress and neonatal asphyxia of the two groups of pregnant women were compared. Results The depth of amniotic fluid in the experimental group was (2.71±1.51)cm before treatment， (3.59±1.51)cm after treatment， (5.92±1.51)cm before amniotic fluid index treatment， (7.82±1.53)cm after treatment， and 3 cases of fetal distress within the fetus. The incidence rate was 2.72%. There were 6 cases of asphyxia in newborns and the incidence was 5.45%. In the control group， the amniotic fluid depth was (2.81±0.29)cm before treatment， (3.54±1.47)cm after treatment，(6.12±1.49)cm before amniotic fluid index treatment， and (7.91±1.62)cm after treatment. There were 3 cases of intrauterine distress， the incidence was 3.00%， 7 cases of neonatal asphyxia， and the incidence was 7.00%. The amniotic fluid depth and amniotic fluid index of pregnant women in the experimental group were not significantly different from those in the control group. According to statistical analysis， the difference was not statistically significant (P>0.05). The probability of occurrence of intrauterine distress and neonatal asphyxia in fetuses of the experimental group was similar to that of pregnant women in the control group. According to statistical analysis， the difference was not statistically significant (P>0.05). Conclusion For the treatment of pregnant women with critical oligohydramnios in late pregnancy， to ensure that the normal fetal heart rate， to give pregnant women intravenous infusion therapy has no obvious curative effect， no significant clinical significance， during the treatment， pregnant women should be specifically checked， clear of etiology， thus symptomatic treatment., http://www.100md.com(杨妍)